Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02839876 · ClinicalTrials.gov registry record · Phase 4
Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT02839876 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 81 participants.
The verdict
NCT02839876, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if intravenous acetaminophen is superior to oral acetaminophen when used as part of a multimodal pathway for primary total hip arthroplasty.
Interventions
- DRUG Oral acetaminophen
- DRUG Intravenous acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2017-03-14 |
| Est. Completion | 2018-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02839876
The ClinicalTrials.gov registry entry for NCT02839876 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oral acetaminophen is the first listed.
NCT02839876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02839876 about?
NCT02839876 is a clinical study titled "Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty". The purpose of this study is to determine if intravenous acetaminophen is superior to oral acetaminophen when used as part of a multimodal pathway for primary total hip arthroplasty.
What is the current status of trial NCT02839876?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 2017-03-14. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT02839876?
The interventions under investigation include: Oral acetaminophen (DRUG), Intravenous acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02839876?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.